GlycoNex Incorporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 0.073 million compared to TWD 0.13 million a year ago. Net loss was TWD 62.93 million compared to TWD 40.69 million a year ago. Basic loss per share from continuing operations was TWD 0.64 compared to TWD 0.42 a year ago. Diluted loss per share from continuing operations was TWD 0.64 compared to TWD 0.42 a year ago. Basic loss per share was TWD 0.64 compared to TWD 0.42 a year ago. Diluted loss per share was TWD 0.64 compared to TWD 0.42 a year ago.
For the nine months, sales was TWD 28.44 million compared to TWD 0.984 million a year ago. Net loss was TWD 150.62 million compared to TWD 125.8 million a year ago. Basic loss per share from continuing operations was TWD 1.54 compared to TWD 1.3 a year ago. Diluted loss per share from continuing operations was TWD 1.54 compared to TWD 1.3 a year ago. Basic loss per share was TWD 1.54 compared to TWD 1.3 a year ago. Diluted loss per share was TWD 1.54 compared to TWD 1.3 a year ago.